17
Participants
Start Date
July 31, 2012
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
Umbilical Cord Blood Administration
The subjects will be undertaken allogeneic umbilical cord blood infusion intravenously or intraarterially under non-myeloablative immunosuppression.
Active Rehabilitation
All subjects should participate in active rehabilitation. They will receive two physical and occupational therapy sessions per day. Post discharge, each participant should continue to receive rehabilitation therapy at least 3 days per week until the study completion.
CHA Bundang Medical Center, CHA University, Seongnam-si
MinYoung Kim, M.D.
OTHER